US Industry Index Makes Case For Strong IP Protection Worldwide 09/02/2018 by William New, Intellectual Property Watch 4 Comments The United States Chamber of Commerce sixth annual International IP Index, released yesterday, highlights positive developments in 50 economies to better protect intellectual property rights so as to reward creativity and innovation. But it also takes aim at practices the US industry group still sees as counterproductive.
New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 by Intellectual Property Watch 3 Comments A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a “devastating disease for which current treatments are ineffective, expensive, and toxic,” the group said.
Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec 06/02/2018 by William New, Intellectual Property Watch 1 Comment A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy.
Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 by Intellectual Property Watch Leave a Comment Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance.
Republic Day Of India Celebration In Geneva: Sounds, Sights, Tastes – And History 30/01/2018 by William New, Intellectual Property Watch 1 Comment Friends and followers of the nation and culture of India gathered in Geneva this week to celebrate India’s Republic Day, with a ceremony and feast held in the halls of the UN World Intellectual Property Organization. Among the many achievements and areas of growth mentioned of the rising economy was its prowess in generic medicines production.
Facing Tense IP And Health Talks, WHO Board Erupts Into Dance (Video) 26/01/2018 by William New and Catherine Saez, Intellectual Property Watch Leave a Comment Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and … dancing.
WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 by Catherine Saez and William New, Intellectual Property Watch 1 Comment The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions.
WTO, WHO, WIPO Symposium To Look At Innovative Technologies And UN SDGs 22/01/2018 by William New, Intellectual Property Watch Leave a Comment Three major international organisations in Geneva dealing with health, trade and intellectual property rights will come together next month to look at how innovative technologies can help to achieve the UN Sustainable Development Goals related to health.
US Working To Block UN High-Level Panel On Access To Medicines Ideas In Geneva And Capitals 22/01/2018 by William New, Intellectual Property Watch Leave a Comment The United States, possibly working with like-minded countries, is working to prevent the further spread among international organisations in Geneva of recommendations put forward by the 2016 United Nations High-Level Panel on Access to Medicines, considering them to be ideological driven and dangerous to economic growth. The comments were made by a US official speaking to a recent US industry event in Washington DC involving many of the US intellectual property attachès, at which two attachés from Geneva described latest developments and strategy for the coming year. A key message from attachès to industry: come to Geneva and engage, starting with this week’s Executive Board meeting at the World Health Organization.
USTR Notorious Markets: Online Ads Still Funding IP Infringement; Alibaba Fires Back About Report 12/01/2018 by William New, Intellectual Property Watch 1 Comment The Office of the United States Trade Representative today released its annual list of the worst outlaw online and physical markets around the world, citing a range of major sources of problems in every part of the world. The list this year highlights new technologies, identifies online advertising as a large revenue source for counterfeiters, and includes Chinese online market Taobao, owned by internet giant Alibaba, for the second year in a row, leading the company to claim bias and politics are at play.